Pharmacovigilance and Risk Management Strategies 2014

This global three-day meeting will provide new insights into the current issues and associated challenges impacting drug safety, focusing primarily on drug products and biologics, throughout all phases of development and marketed use. Top pharmaceutical, biotechnology, and regulatory thought leaders convene each January to discuss new and updated legislation in various ICH regions, current regulatory framework for pharmacovigilance in global regions, operational challenges of implementing global Benefit-risk analyses and risk management plans, the impact of social media, and the role of epidemiology in safety analysis